|
|
| |
|
|
| |
Spices Board of
India Honors Dr. Majeed |
|
| |
| |
The Indian government has again recognized
Dr. Muhammed Majeed for his continuing efforts in
new product development.
The Spices Board of India honored Dr. Majeed for pioneering
the development and commercialization of Garcinia
cambogia.
|
|
|
| |
NEW PRODUCTS: Bacopin™ (Bacopa
monniera) |
|
| |
Often referred to as brahmi, Bacopa
monniera was prized by Ayurvedic physicians as an effective
brain tonic. Bacopin™ contains bacosides, the active principles
responsible for improving memory related functions. These compounds
are attributed with the capability of enhancing the efficiency
of transmission of nerve impulses, thereby strengthening memory
and cognition. Bacopin™ is a trademark of Sabinsa Corporation.
Please feel free to call for more information, or to speak
directly with one of our scientific staff consultants about
Bacopin or other quality Sabinsa products. |
|
| |
|
|
| |
GLUCOSAMINE
S04 Vs.
HCl Which is the preferred form? |
|
| |
When Dr. Badmaev teamed up with Sabinsa, a
natural alliance occurred, the results of which were two-fold.
Firstly, Dr. Badmaev's wealth of knowledge led to the enhancement
of the scientific and technical backup which Sabinsa could
provide for its products and customers. Secondly, it resulted
in the continuation of the long standing Badmaev family traditions.
Dr. Badmaev is actively involved in organizing clinical investigations
to support Sabinsa's products. He reaches out to both the
academic and business Community in the course of developing
an elaborate database documenting the safety and health benefits
of Sabinsa's products.
The Joint efforts of Sabinsa and Dr. Badmaev, in coordination
with a well established international marketing company, have
resulted in the successful launching of the Badmacv line of
products back into Dr. Badmaev's native Russia. |
|
| |
|
|
| |
VISIT
WWW.SABINSA.COM ON THE INTERNET |
|
| |
Glucosamine sulfate is the preferred form
of glucosamine for therapeutic use, mainly as an antiarthritic
agent. It is an effective means of providing glucosamine orally
and as a building block for the regeneration
of cartilage glycosaminoglycans lost during the progression
of osteoarthritis.
- Glucosamine sulfate occurs naturally in the
human body and is almost devoid of toxicity, making it suitable
for long-term clinical use1.
- The chondrometabolic, antireactive and antiarthritis
properties of this form have been investigated extensively
and are supported by controlled clinical trials2.
- Pharmacokinetic studies revealed that close
to 90% of orally administered glucosamine sulfate is absorbed3.
- Glucosamine sulfate, in vivo, breaks down into glucosamine
and sulfate ions. Glucosamine hydrocholoride, on the other
hand, breaks down into glucosamine and free hydrochloric
acid. The acid would increase gastric acidity and produce
the associated disturbances in vivo.
- The sulfate ions produced from glucosamine sulfate, on
the other hand, participate in chondrometabolic processes.
They influence the incorporation of glucosamine and sulfate
into the tissues. In a study with gastric mucosal segments,
a sulfate content of 300 m mole was found to induce maximum
incorporation. Chlorate was found to inhibit glycosylation
and induce the formation of low molecular weight mucin polymer.
The results of this study revealed that sulfate availability
is essential for the formation of high molecular weight
mucin polymer. The presence of sulfate ion would therefore
enhance the antiarthritic properties of glucosamine.
References:
- Rovalti, L.C., (1992). Antireactive properties of chondroprotective
drugs. Int. J. Tissue Reactions, 14(5), 253-261.
- Reichelt, A. et al. (1994). Efficacy and safety of intramuscular
glucosamine sulfate in osteoarthritis of the knee, a randomized,
placebo-controlled double blind study. Arzneim-Forsch Drug
Res. 44(l)(1), 75-80.
- Setnikar, 1. et al. (1993). Pharmacokinetics of glucosamine
in man. Arzneim-Forsch Drug Res. 43(11)(10), 1109-1113.
- Liau, Y. H. et al. (1992). Role of sulfation in post-translational
processing of gastric mucins. Int. J. Riochem. 24(7), 1023-1028.
|
|
| |
|
|
| |
SCIENTIFIC
FOCUS:
Sam P. Kumar Ph.D., Sabinsa Research Group |
|
| |
| Senior
Director of Natural Products Chemistry, Dr. Kumar takes
primary responsibility for developing new products from
natural sources to address serious medical conditions.
Dr. Kumar has 23 years experience as an organic chemist.
His experience includes the successful synthesis of
peptides, hormones, Prostaglandins, antiinflammatorv
drugs, antivirals, antihistamines and aroma chemicals.
Prior to joining Sabinsa, he was Senior Staff Chemist
at Yale University, and served as Organic Biochemist
for Elan Chemicals, Newark, NJ. He holds a number of
patents and is widely published in professional journals.
|
|
|
|
| |
|
|
| |
Sabinsa receives Kosher Certification |
|
| |
Sabinsa recently announced that it has been authorized
by the Orthodox Union to place the O.U. symbol certifying products
listed under their respective brand names as kosher and pareve.
A copy of Sabinsa's kosher certified product list is available
upon request.
|
|
| |
|
|
| |
SABINSA-ON-WHEELS
UPDATE:
COLORADO AND ARIZONA
Sabinsa's educational training
seminar will be presented at the Denver Marriott
South (Englewood, Colorado) on May 14, and the
following day at the Sheraton Mesa Hotel (Mesa,
Arizona) on May 15.
For reservations contact Sabinsa
at 908-777-1111 (8:30 a.m. - 6 p.m. EDT).
|
|
|
|
|
